AbbVie Inc.: accounts_receivable
| Value | {"amount": 11237000000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-06-30) |
| Status | current |
| Entity | AbbVie Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:44:37.484490+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/00f83d72-2ec1-492c-be88-a7740aede927
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001551152-22-000030Retrieved: 2026-08-19T15:44:37.484490+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001551152/accounts-receivable/2022-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/00f83d72-2ec1-492c-be88-a7740aede927
History
- no predecessors — first report